Bile acid metabolism in cirrhotic liver tissue--altered synthesis and impaired hepatic secretion
- PMID: 3677416
- DOI: 10.1016/0009-8981(87)90289-0
Bile acid metabolism in cirrhotic liver tissue--altered synthesis and impaired hepatic secretion
Abstract
Bile acid analysis of mild and severe cirrhotic liver showed that with the advancement of cirrhosis the concentration of chenodeoxycholic acid in liver tissue becomes higher, resulting in the lower ratio of cholic to chenodeoxycholic acid probably due to the progressive alteration of cholic and chenodeoxycholic acid synthesis with the advancement of liver cirrhosis. Bile acid analysis of paired liver and bile of severe cirrhosis showed that the ratio of cholic to chenodeoxycholic acid in liver was lower than that in bile or even with that in bile. This can be explained by postulating the impaired hepatic secretion of bile acids, especially chenodeoxycholic acid. The impaired secretion together with the relatively well preserved chenodeoxycholic acid synthesis results in the accumulation of chenodeoxycholic acid in liver tissue with cirrhosis.
Similar articles
-
Pool size, synthesis, and turnover of sulfated and nonsulfated cholic acid and chenodeoxycholic acid in patients with cirrhosis of the liver.Gastroenterology. 1978 Mar;74(3):572-7. Gastroenterology. 1978. PMID: 631488
-
Equilibration of labelled and endogenous bile acids in patients with liver cirrhosis after administration of (24-14C)cholic and chenodeoxycholic acids.Scand J Clin Lab Invest. 1991 Apr;51(2):197-208. doi: 10.1080/00365519109091108. Scand J Clin Lab Invest. 1991. PMID: 2042024
-
[Bile acid metabolism in hepatic tissue of healthy subjects and in patients with liver cirrhosis].Z Gastroenterol. 1973 Apr;11(3):203-16. Z Gastroenterol. 1973. PMID: 4803420 German. No abstract available.
-
Disturbances of bile acid metabolism in parenchymal liver cell disease.Clin Gastroenterol. 1977 Jan;6(1):25-43. Clin Gastroenterol. 1977. PMID: 330050 Review. No abstract available.
-
Overview of clinical aspects of bile salt physiology.J Pediatr Gastroenterol Nutr. 1983 May;2(2):337-45. doi: 10.1097/00005176-198302020-00024. J Pediatr Gastroenterol Nutr. 1983. PMID: 6348231 Review. No abstract available.
Cited by
-
Ursodeoxycholic acid administration on bile acid metabolism in patients with early stages of primary biliary cirrhosis.Dig Dis Sci. 1993 May;38(5):896-902. doi: 10.1007/BF01295917. Dig Dis Sci. 1993. PMID: 8482188
-
Engineered three-dimensional liver mimics recapitulate critical rat-specific bile acid pathways.Tissue Eng Part A. 2011 Mar;17(5-6):677-89. doi: 10.1089/ten.TEA.2010.0423. Epub 2010 Dec 19. Tissue Eng Part A. 2011. PMID: 20929286 Free PMC article.
-
Ursodeoxycholic acid therapy in chronic active hepatitis.Postgrad Med J. 1990 Sep;66(779):781-3. doi: 10.1136/pgmj.66.779.781. Postgrad Med J. 1990. PMID: 2235818 Free PMC article.
-
Alterations of bile acid composition in gallstones, bile, and liver of patients with hepatolithiasis, and their etiological significance.Dig Dis Sci. 1993 Nov;38(11):2130-41. doi: 10.1007/BF01297095. Dig Dis Sci. 1993. PMID: 8223090
-
Clinical pharmacokinetics of therapeutic bile acids.Clin Pharmacokinet. 1996 May;30(5):333-58. doi: 10.2165/00003088-199630050-00002. Clin Pharmacokinet. 1996. PMID: 8743334 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical